(Total Views: 343)
Posted On: 04/07/2019 4:12:57 PM
Post# of 36569
This is a smart article on valuation for a biotech:
https://www.nature.com/bioent/2003/030101/ful...1-813.html
Since NGIO shares aren’t listed as we await to see the spin-off, they have no enterprise (or any type of) value. But, we did see NGIO shares used as a form of currency. It’s exciting that the spin-off and potential merger is close.
https://www.nature.com/bioent/2003/030101/ful...1-813.html
Since NGIO shares aren’t listed as we await to see the spin-off, they have no enterprise (or any type of) value. But, we did see NGIO shares used as a form of currency. It’s exciting that the spin-off and potential merger is close.
(0)
(0)
